EP2854936A2 - Leads with tip electrode for electrical stimulation systems and methods of making and using - Google Patents
Leads with tip electrode for electrical stimulation systems and methods of making and usingInfo
- Publication number
- EP2854936A2 EP2854936A2 EP13729559.8A EP13729559A EP2854936A2 EP 2854936 A2 EP2854936 A2 EP 2854936A2 EP 13729559 A EP13729559 A EP 13729559A EP 2854936 A2 EP2854936 A2 EP 2854936A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- lead
- electrode
- electrodes
- tip
- tip electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0534—Electrodes for deep brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/0565—Electrode heads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
Definitions
- the invention is directed to the area of electrical stimulation systems and methods of making and using the systems.
- the present invention is also directed to electrical stimulation leads with a tip electrode designed to facilitate retention of the tip electrode on the distal end of the lead, as well as methods of making and using the leads and electrical stimulation systems.
- Deep brain stimulation can be useful for treating a variety of conditions. Deep brain stimulation can be useful for treating, for example, Parkinson's disease, dystonia, essential tremor, chronic pain, Huntington's Disease, levodopa-induced dyskinesias and rigidity, bradykinesia, epilepsy and seizures, eating disorders, and mood disorders.
- a lead with a stimulating electrode at or near a tip of the lead provides the stimulation to target neurons in the brain.
- Magnetic resonance imaging (“MRI”) or computerized tomography (“CT”) scans can provide a starting point for determining where the stimulating electrode should be positioned to provide the desired stimulus to the target neurons.
- MRI Magnetic resonance imaging
- CT computerized tomography
- electrical stimulus current can be delivered through selected electrodes on the lead to stimulate target neurons in the brain.
- the electrodes are formed into rings disposed on a distal portion of the lead.
- the stimulus current projects from the ring electrodes equally in every direction. Because of the ring shape of these electrodes, the stimulus current cannot be directed to one or more specific positions around the ring electrode (e.g., on one or more sides, or points, around the lead). Consequently, undirected stimulation may result in unwanted stimulation of neighboring neural tissue, potentially resulting in undesired side effects.
- One embodiment is an implantable electrical stimulation lead including a lead body having a distal portion, a distal tip, and a proximal portion; a plurality of electrodes disposed along the distal portion of the lead body; a plurality of terminals disposed along the proximal portion of the lead; and a plurality of conductors, each conductor electrically coupling at least one of the electrodes to at least one of the terminals.
- the plurality of electrodes includes a tip electrode disposed on the distal tip of the lead body.
- the tip electrode has a base and a separate plug attached to the base.
- the base defines an interior lumen closed at one end by the plug. A portion of the lead body extends into the interior lumen of the base.
- an implantable electrical stimulation lead including a lead body having a distal portion, a distal tip, and a proximal portion; a plurality of electrodes disposed along the distal portion of the lead body; a plurality of terminals disposed along the proximal portion of the lead; and a plurality of conductors, each conductor electrically coupling at least one of the electrodes to at least one of the terminals.
- the plurality of electrodes includes a tip electrode disposed on the distal tip of the lead body.
- the tip electrode has an electrode body, a stem extending from the electrode body, and a plurality of shaped retention features extending from the stem. A portion of the lead body extends around the stem and shaped retention features. The shaped retention features facilitate retention of the tip electrode on the lead body.
- an implantable electrical stimulation lead including a lead body having a distal portion, a distal tip, and a proximal portion; a plurality of electrodes disposed along the distal portion of the lead body; a plurality of terminals disposed along the proximal portion of the lead; and a plurality of conductors, each conductor electrically coupling at least one of the electrodes to at least one of the terminals.
- the plurality of electrodes includes a tip electrode disposed on the distal tip of the lead body.
- the tip electrode has an electrode body, a stem extending from the electrode body, and a flange attached to the stem opposite the electrode body. A portion of the lead body extends around the stem and flange. The flange facilitates retention of the tip electrode on the lead body.
- a further embodiment is an implantable electrical stimulation lead including a lead body having a distal portion, a distal tip, and a proximal portion; a plurality of electrodes disposed along the distal portion of the lead body; a plurality of terminals disposed along the proximal portion of the lead; and a plurality of conductors, each conductor electrically coupling at least one of the electrodes to at least one of the terminals.
- the plurality of electrodes includes a tip electrode disposed on the distal tip of the lead body.
- the tip electrode has an electrode body and the electrode body defines an interior lumen and a plurality of protrusions extending into the interior lumen.
- a portion of the lead body extends into the interior lumen of the electrode body.
- the plurality of protrusions in the interior lumen facilitates retention of the tip electrode on the lead body and hinders rotation of the tip electrode around the distal tip of the lead body.
- an implantable electrical stimulation lead including a lead body comprising a distal portion, a distal tip, and a proximal portion; a plurality of electrodes disposed along the distal portion of the lead body; a plurality of terminals disposed along the proximal portion of the lead; and a plurality of conductors, each conductor electrically coupling at least one of the electrodes to at least one of the terminals.
- the plurality of electrodes includes a tip electrode disposed on the distal tip of the lead body.
- the tip electrode has an electrode body and a plurality of arms extending from the electrode body.
- the electrode body defines an interior lumen and an opening to the interior lumen.
- the plurality of arms extends over the opening to the interior lumen.
- a portion of the lead body extends into the interior lumen of the electrode body and around the plurality of arms. The plurality of arms facilitates retention of the tip electrode on the lead body.
- FIG. 1 is a schematic side view of one embodiment of a device for brain stimulation, according to the invention.
- FIG. 2 is a schematic perspective view of one embodiment of a portion of a lead having a plurality of segmented electrodes and a tip electrode, according to the invention
- FIG. 3 is a schematic perspective view of a second embodiment of a portion of a lead having a plurality of segmented electrodes and a tip electrode, according to the invention
- FIG. 4 is a schematic diagram of radial current steering along various electrode levels along the length of a lead, according to the invention.
- FIG. 5 is a schematic cross-sectional view of one embodiment of a two piece tip electrode, according to the invention.
- FIG. 6 A is a schematic side view of an embodiment of a portion of a lead with a two-piece tip electrode prior to coupling of the two pieces together, according to the invention
- FIG. 6B is a schematic side view of the portion of the lead of Figure 6 A with the two pieces of the tip electrode coupled together, according to the invention.
- FIG. 7 is a schematic cross-sectional view of one embodiment of a tip electrode with a stem, according to the invention.
- FIG. 8 A is a schematic perspective view of one embodiment of a tip electrode with a stem and flange, according to the invention.
- FIG. 8B is a schematic perspective view of one embodiment of a pre-electrode that can be ground down to form the tip electrode of Figure 8 A, according to the invention.
- FIG. 9 A is a schematic perspective view of one embodiment of a tip electrode with a shaped interior lumen, according to the invention.
- FIG. 9B is a schematic perspective view of one embodiment of a pre-electrode that can be ground down to form the tip electrode of Figure 9A, according to the invention.
- FIG. 10A is a schematic perspective view of one embodiment of a tip electrode with an interior lumen and multiple arms extending from an edge of the electrode over the opening of the interior lumen, according to the invention.
- FIG. 1 OB is a schematic perspective view of one embodiment of a pre-electrode that can be ground down to form the tip electrode of Figure 10A, according to the invention.
- the invention is directed to the area of electrical stimulation systems and methods of making and using the systems.
- the present invention is also directed to electrical stimulation leads with a tip electrode designed to facilitate retention of the tip electrode on the distal end of the lead, as well as methods of making and using the leads and electrical stimulation systems.
- a lead for deep brain stimulation may include stimulation electrodes, recording electrodes, or a combination of both.
- the stimulation or recording electrodes of the lead can include a tip electrode and one or more ring electrodes or segmented electrodes or any combination thereof.
- at least some of the stimulation electrodes, recording electrodes, or both are provided in the form of segmented electrodes that extend only partially around the circumference of the lead.
- these segmented electrodes may be provided in sets of electrodes, with each set having electrodes radially distributed about the lead at a particular longitudinal position.
- the segmented electrodes can be provided in any other suitable arrangement including, for example, arranging segmented electrodes in one or more helices around the circumference of the lead or arranging segmented electrodes along only one side of the lead.
- a practitioner may determine the position of the target neurons using the recording electrode(s) and then position the stimulation electrode(s) accordingly without removal of a recording lead and insertion of a stimulation lead.
- the same electrodes can be used for both recording and stimulation.
- separate leads can be used; one with recording electrodes which identify target neurons, and a second lead with stimulation electrodes that replaces the first after target neuron identification.
- a lead may include recording electrodes spaced around the circumference of the lead to more precisely determine the position of the target neurons.
- the lead is rotatable so that the stimulation electrodes can be aligned with the target neurons after the neurons have been located using the recording electrodes.
- the leads are described herein relative to use for deep brain stimulation, but it will be understood that any of the leads can be used for applications other than deep brain stimulation including, but not limited to, spinal cord stimulation, dorsal root ganglion stimulation, and stimulation of other nerves, muscle tissue, or organs.
- Deep brain stimulation devices and leads are described in, for example, U.S. Patent No. 7,809,446; and U.S. Patent Application Publications Nos. 2007/0150036;
- Figure 1 illustrates one embodiment of a device 100 for brain stimulation.
- the device includes a lead 110, a plurality of electrodes 125 disposed at least partially about a circumference of the lead 110, a plurality of terminals 135, a connector 130 for connection of the electrodes to a control unit, and a stylet 140 for assisting in insertion and positioning of the lead in the patient's brain.
- the stylet 140 can be made of a rigid material. Examples of suitable materials for the stylet include, but are not limited to, tungsten, stainless steel, and plastic.
- the stylet 140 may have a handle 150 to assist insertion into the lead 110, as well as rotation of the stylet 140 and lead 110.
- the connector 130 fits over a proximal end of the lead 110, preferably after removal of the stylet 140.
- the control unit (not shown) is typically an implantable pulse generator that can be implanted into a patient's body, for example, below the patient's clavicle area.
- the pulse generator can have eight stimulation channels which may be independently programmable to control the magnitude of the current stimulus from each channel. In some cases the pulse generator may have more than eight stimulation channels (e.g., 16-, 32-, or more stimulation channels).
- the control unit may have one, two, three, four, or more connector ports, for receiving the plurality of terminals 135 at the proximal end of the lead 110.
- access to the desired position in the brain can be accomplished by drilling a hole in the patient's skull or cranium with a cranial drill
- the lead 110 can be inserted into the cranium and brain tissue with the assistance of the stylet 140.
- the lead 110 can be guided to the target location within the brain using, for example, a stereotactic frame and a microdrive motor system.
- the microdrive motor system can be fully or partially automatic.
- the microdrive motor system may be configured to perform one or more the following actions (alone or in combination): insert the lead 110, retract the lead 110, or rotate the lead 110.
- measurement devices coupled to the muscles or other tissues stimulated by the target neurons, or a unit responsive to the patient or clinician can be coupled to the control unit or microdrive motor system.
- the measurement device, user, or clinician can indicate a response by the target muscles or other tissues to the stimulation or recording electrode(s) to further identify the target neurons and facilitate positioning of the stimulation electrode(s). For example, if the target neurons are directed to a muscle experiencing tremors, a measurement device can be used to observe the muscle and indicate changes in tremor frequency or amplitude in response to stimulation of neurons.
- the patient or clinician may observe the muscle and provide feedback.
- the lead 110 for deep brain stimulation can include stimulation electrodes, recording electrodes, or both.
- the lead 110 is rotatable so that the stimulation electrodes can be aligned with the target neurons after the neurons have been located using the recording electrodes.
- Stimulation electrodes may be disposed on the circumference of the lead 110 to stimulate the target neurons. Stimulation electrodes may be ring-shaped so that current projects from each electrode equally in every direction from the position of the electrode along a length of the lead 110. Ring electrodes, however, typically do not enable stimulus current to be directed to only one side of the lead. Segmented electrodes, however, can be used to direct stimulus current to one side, or even a portion of one side, of the lead. When segmented electrodes are used in conjunction with an implantable pulse generator that delivers constant current stimulus, current steering can be achieved to more precisely deliver the stimulus to a position around an axis of the lead (i.e., radial positioning around the axis of the lead).
- segmented electrodes can be utilized in addition to, or as an alternative to, ring electrodes. Though the following description discusses stimulation electrodes, it will be understood that all configurations of the stimulation electrodes discussed may be utilized in arranging recording electrodes as well.
- Figures 2 and 3 illustrate embodiments of a distal portion of a lead 200 for brain stimulation.
- the lead 200 includes a lead body 210, one or more optional ring electrodes 220, a plurality of segmented electrodes 230, and a tip electrode 240. It will be understood that other lead embodiments can include only a tip electrode and one or more ring electrodes or only a tip electrode and one or more segmented electrodes. Other embodiments can include a tip electrode and a combination of ring and segmented electrodes in arrangements other than those illustrated in Figures 2 and 3.
- the lead body 210 can be formed of a biocompatible, non-conducting material such as, for example, a polymeric material. Suitable polymeric materials include, but are not limited to, silicone, polyurethane, polyurea, polyurethane-urea, polyethylene, or the like.
- the lead 200 may be in contact with body tissue for extended periods of time.
- the lead 200 has a cross-sectional diameter of no more than 1.5 mm and may be in the range of 1 to 1.5 mm.
- the lead 200 has a length of at least 10 cm and the length of the lead 200 may be in the range of 25 to 70 cm.
- the electrodes 220, 230, 240 may be made using a metal, alloy, conductive oxide, or any other suitable conductive biocompatible material.
- suitable materials include, but are not limited to, platinum, platinum iridium alloy, iridium, titanium, tungsten, palladium, palladium rhodium, or the like.
- the electrodes are made of a material that is biocompatible and does not substantially corrode under expected operating conditions in the operating environment for the expected duration of use.
- Each of the electrodes 220, 230, 240 can either be used or unused (OFF).
- the electrode can be used as an anode or cathode and carry anodic or cathodic current.
- an electrode might be an anode for a period of time and a cathode for a period of time.
- Stimulation electrodes in the form of ring electrodes 220 may be disposed on any part of the lead body 210, usually near a distal end of the lead 200.
- a stimulation electrode in the form of tip electrode 240 is disposed at the distal end of the lead.
- the lead 200 includes one ring electrode 220 and one tip electrode 240. Any number of ring electrodes 220 may be disposed along the length of the lead body 210 including, for example, one, two three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen or more ring electrodes 220. It will be understood that any number of ring electrodes may be disposed along the length of the lead body 210.
- the ring electrode(s) 220 and tip electrode 240 are
- the tip electrode 240 also extends over the tip of the lead.
- the outer diameters of the ring electrode(s) 220 and tip electrode 240 are independently substantially equal to the outer diameter of the lead body 210.
- the length of the ring electrode(s) 220 and tip electrode 240 may independently vary according to the desired treatment and the location of the target neurons or other tissue. In some embodiments the length of one or more of the ring electrode(s) 220 and tip electrode 240 are less than or equal to the corresponding diameters of the ring electrode(s) 220 and tip electrode 240.
- the lengths of one or more of the ring electrode(s) 220 and tip electrode are greater than the corresponding diameters of the ring electrode(s) 220 and tip electrode 240.
- the surface area of the tip electrode 240 and one of the ring electrode(s) 220 may be equal of substantially equal (e.g., within 10% or 5% of each other).
- Deep brain stimulation leads and other leads may include one or more sets of segmented electrodes. Segmented electrodes may provide for superior current steering than ring electrodes because target structures in deep brain stimulation are not typically symmetric about the axis of the distal electrode array. Instead, a target may be located on one side of a plane running through the axis of the lead.
- RSEA radially segmented electrode array
- current steering can be performed not only along a length of the lead but also around a circumference of the lead. This provides precise three- dimensional targeting and delivery of the current stimulus to neural target tissue, while potentially avoiding stimulation of other tissue. Examples of leads with segmented electrodes include U.S. Patents Nos. 8,295,944; and 8,391,985; and U.S. Patent
- the lead 200 is shown having a plurality of segmented electrodes 230.
- Any number of segmented electrodes 230 may be disposed on the lead body 210 including, for example, one, two three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen or more segmented electrodes 230. It will be understood that any number of segmented electrodes 230 may be disposed along the length of the lead body 210.
- the segmented electrodes 230 may be grouped into sets of segmented electrodes, where each set is disposed around a circumference of the lead 200 at a particular longitudinal portion of the lead 200.
- the lead 200 may have any number of segmented electrodes 230 in a given set of segmented electrodes.
- the lead 200 may have one, two, three, four, five, six, seven, eight, or more segmented electrodes 230 in a given set.
- each set of segmented electrodes 230 of the lead 200 contains the same number of segmented electrodes 230.
- the segmented electrodes 230 disposed on the lead 200 may include a different number of electrodes than at least one other set of segmented electrodes 230 disposed on the lead 200.
- the segmented electrodes 230 may vary in size and shape. In some embodiments, the segmented electrodes 230 are all of the same size, shape, diameter, width or area or any combination thereof.
- the segmented electrodes 230 of each circumferential set may be identical in size and shape.
- Each set of segmented electrodes 230 may be disposed around the circumference of the lead body 210 to form a substantially cylindrical shape around the lead body 210.
- the spacing between individual electrodes of a given set of the segmented electrodes may be the same, or different from, the spacing between individual electrodes of another set of segmented electrodes on the lead 200.
- equal spaces, gaps or cutouts are disposed between each segmented electrode 230 around the circumference of the lead body 210.
- the spaces, gaps or cutouts between the segmented electrodes 230 may differ in size or shape. In other embodiments, the spaces, gaps, or cutouts between segmented electrodes 230 may be uniform for a particular set of the segmented electrodes 230, or for all sets of the segmented electrodes 230. The sets of segmented electrodes 230 may be positioned in irregular or regular intervals along a length the lead body 210.
- Conductor wires that attach to the tip electrode 240, ring electrode(s) 220, and segmented electrodes 230 extend along the lead body 210. These conductor wires may extend through the material of the lead 200 or along one or more lumens defined by the lead 200, or both. The conductor wires are presented at a connector (via terminals) for coupling of the electrodes 220, 230, 240 to a control unit (not shown).
- the lead 200 includes a tip electrode 240, ring electrode(s) 220 and segmented electrodes 230, the ring electrodes 220 and the segmented electrodes 230 may be arranged in any suitable configuration.
- the tip electrode 240 will generally be at the distal tip of any arrangement containing a tip electrode 240.
- the tip electrode 240 and ring electrode 220 can flank the two sets of segmented electrodes 230 (see e.g., Figure 2).
- the tip electrode 240 and ring electrode 220 can be disposed distal to the two sets of segmented electrodes 230 (see e.g., Figure 3). It will be understood that other configurations are possible as well ⁇ e.g. , alternating ring and segmented electrodes, or the like).
- tip electrode 240 may be disposed on the lead 200.
- the lead may include a ring electrode, two sets of segmented electrodes, each set formed of three segmented electrodes 230, and a tip electrode at the end of the lead.
- This configuration may simply be referred to as a 1-3-3 - 1 configuration as illustrated in Figure 2. It may be useful to refer to the electrodes with this shorthand notation.
- Figure 3 illustrates a lead with a 3-3-1-1 configuration. Possible configurations for a 16-electrode lead with a tip electrode include, but are not limited to, 3- 3.3.3.3.I and 1-3-3-2-3-3-1.
- Markers or other indicia may be provided sot that the practitioner can determine the orientation of the segmented electrodes when implanted. Examples of suitable markers and indicia can be found in, for example, U.S. Patent Application Publications Nos.
- Figure 4 is a schematic diagram to illustrate radial current steering along various electrode levels along the length of the lead 200. While conventional lead configurations with ring electrodes are only able to steer current along the length of the lead (the z-axis), the segmented electrode configuration is capable of steering current in the x-axis, j-axis as well as the z-axis. Thus, the centroid of stimulation may be steered in any direction in the three-dimensional space surrounding the lead 200. In some embodiments, the radial distance, r, and the angle ⁇ around the circumference of the lead 200 may be dictated by the percentage of anodic current (recognizing that stimulation predominantly occurs near the cathode, although strong anodes may cause stimulation as well) introduced to each electrode.
- the configuration of anodes and cathodes along the segmented electrodes allows the centroid of stimulation to be shifted to a variety of different locations along the lead 200.
- the centroid of stimulation can be shifted at each level along the length of the lead 200.
- the use of multiple sets of segmented electrodes at different levels along the length of the lead allows for three-dimensional current steering.
- the sets of segmented electrodes are shifted collectively (i.e., the centroid of simulation is similar at each level along the length of the lead).
- each set of segmented electrodes is controlled independently.
- Each set of segmented electrodes may contain two, three, four, five, six, seven, eight or more segmented electrodes. It will be understood that different stimulation profiles may be produced by varying the number of segmented electrodes at each level. For example, when each set of segmented electrodes includes only two segmented electrodes, uniformly distributed gaps (inability to stimulate selectively) may be formed in the stimulation profile. In some embodiments, at least three segmented electrodes 230 in a set are utilized to allow for true 360° selectivity.
- measurement devices coupled to the muscles or other tissues stimulated by the target neurons or a unit responsive to the patient or clinician can be coupled to the control unit or microdrive motor system.
- measurement device user, or clinician can indicate a response by the target muscles or other tissues to the stimulation or recording electrodes to further identify the target neurons and facilitate positioning of the stimulation electrodes.
- a measurement device can be used to observe the muscle and indicate changes in tremor frequency or amplitude in response to stimulation of neurons.
- the patient or clinician may observe the muscle and provide feedback.
- a tip electrode can be used in combination with one or more ring electrodes, one or more segmented electrodes, or any combination of ring and segmented electrodes.
- a tip electrode may be selected to have the same, or substantially the same, surface area as one or more ring electrodes of the lead.
- a tip electrode can be designed to improve retention of the tip electrode on the lead.
- a tip electrode may have a hollow cylindrical base and a separate plug that can be attached to the base.
- Figure 5 illustrates a tip electrode 540 having a base 542 and a separate plug 544.
- the base 542 and plug 544 are typically formed of a suitable metal, alloy, or other conductor.
- the base 542 is a hollow tubular structure with an interior lumen 541 with openings at opposing ends of the tubular structure that will allow material to flow through the base.
- the open interior lumen 541 facilitates retention of the base on the lead.
- the base 542 includes a distal opening 543 that is shaped to receive the plug 544.
- the base 542 will have sloped edges 545 at the distal opening 543 that correspond to sloped edges 547 on the plug 544 to facilitate mating of the base and plug. It will be understood that other configurations of the distal opening and corresponding surface on the plug can be used to facilitate mating of the base and plug.
- Figures 6 A and 6B illustrate a distal portion of one embodiment of a lead 500 having a tip electrode 540 with a base 542 and a separate plug 544.
- the lead also includes a lead body 510, 510' and one or more additional electrodes 520.
- the lead body 510 is formed by molding the lead body 510' between the electrodes 520 (and, at least in some embodiments, between the electrodes and the terminals at the proximal end of the lead - see, Figure 1).
- the material of the lead body 510 can also be molded between the distal-most electrode 520 and the base 542 of the tip electrode 540. During the molding process, the material that will form the lead body can flow into the interior lumen 541 (see, Figure 5) of the base 542. Any molding process can be used including, but not limited to, injection molding.
- the lead body 510, 510' can be formed of any material that can be molded by flowing the material around the other components and then solidify the material to form the lead body.
- Any suitable process can be used to solidify the material including, but not limited to, cooling the material, photocuring, heat curing, crosslinking, and the like.
- suitable materials can include silicone, polyurethane, polyetheretherketone, and the like.
- 2011/0078900 can be modified to include a tip electrode (by, for example, replacing the distal-most ring electrode in Figures 7A-7E with a tip electrode).
- the lead body 510 When the lead body 510 is formed, the lead body will extend into the interior lumen of the base 542 and facilitate retention of the tip electrode 540 on the lead 500.
- the plug 544 can be attached (preferably, permanently) to the base 542 by, for example, welding, soldering, adhesive (preferably, conductive adhesive), press- fit, crimping, threading on the base and plug, or any combination thereof or any other suitable fastening arrangement.
- the plug 544 and base 542 are also in electrical communication with each through the fastening arrangement.
- a portion of the lead body may be removed from the distal opening 543 of the base 542 to allow attachment of the plug 544 to the base.
- a tip electrode conductor (not shown) is attached, welded, soldered, or otherwise electrically coupled to the tip electrode 540.
- the coupling of the tip electrode conductor may occur prior to forming the lead body 510.
- the tip electrode conductor like other conductors in the lead, extends along the lead and is electrically coupled to one of the terminals disposed along the proximal end of the lead.
- the tip electrode conductor is coupled to the base 542 at, for example, the surface of the interior lumen 541 or the proximal end of the base.
- the tip electrode conductor is attached to the plug 544.
- a tip electrode may include a stem with one or more features to facilitate retention of the tip electrode at the distal end of the lead.
- Figure 7 illustrates in cross-section one embodiment of a tip electrode 740 having an electrode body 742 and a stem 746 with shaped retention features 748 formed on the stem.
- the electrode body 742 includes at least a portion of the surface that is exposed to tissue, when the lead is implanted, for providing stimulation to the tissue.
- the material of the lead body forms around the stem of the tip electrode and facilitates retention of the tip electrodes within the lead body of the resulting lead.
- the shaped retention features 748 hinder extraction of the tip electrode from the lead body.
- the shaped retention features 748 on the stem typically extend away from the adjacent portions of the stem 746 to interact with material at the distal end of the lead, such as the lead body, to resist withdrawal of the tip electrode 740 from the distal end of the lead.
- suitable shaped retention features include, but are not limited to, one or more stepped features, sloped protrusions, flanges, teeth, protruding threads, or the like formed on the stem or a roughened surface formed on the stem.
- the shaped retention features have a sloping surface 760 on one side and a stepped surface 762 on the other side to resist withdrawal from the distal end of the lead.
- a tip electrode conductor (not shown) is attached, welded, soldered, or otherwise electrically coupled to the tip electrode 740.
- the tip electrode conductor is coupled to the stem 746.
- the tip electrode conductor could be coupled to the side of the stem 746 or the proximal end of the stem.
- the tip electrode conductor can be attached to the main portion of the tip electrode (i.e., the non-stem portion of the tip electrode).
- the tip electrode conductor extends along the lead and is electrically coupled to one of the terminals disposed along the proximal end of the lead.
- Figure 8A illustrates another embodiment of a tip electrode 840 that includes an electrode body 842 and a stem 846 with a flange 850 attached to the end of the stem.
- the electrode body 842 includes at least a portion of the surface that is exposed to tissue, when the lead is implanted, for providing stimulation to the tissue.
- the flange may have any suitable shape including, but not limited to, disc-shaped, square-shaped, hexagonal-shaped, octagonal-shaped, triangular-shaped, and the like.
- the flange is gear-shaped with a disc having regular indentations 852 formed in the sides of the disc leaving regular protrusions 854 around the edge of the disc.
- the tip electrode conductor (not shown) can be attached to any portion of the tip electrode including, but not limited to, the flange 850, the protrusions 854 of the flange, or the indentations 852 within the flange.
- the material of the lead body forms around the stem 846 and flange 850 of the tip electrode 840 which facilitates retention of the tip electrode within the lead body of the resulting lead.
- the flange 850 hinders extraction of the tip electrode 840 from the lead body.
- Portions of the lead body formed within the indentations 852 and around the protrusions 854 of the flange may facilitate both retention of the tip electrode on the lead and reduce the likelihood of rotation of the tip electrode.
- a non-circular flange will provide some resistance to rotation of the tip electrode.
- a pre-electrode 840' as illustrated in Figure 8B, is provided during manufacture. The lead body is formed around this pre-electrode 840'. Then the lead body and pre-electrode 840' are ground down to obtain the tip electrode 840 of Figure 8 A. This grinding process also removes excess lead body material leaving the lead body at the desired diameter.
- Figure 9A illustrates an embodiment of a tip electrode 940 with an electrode body 942 and an interior lumen 941.
- the electrode body 942 includes at least a portion of the surface that is exposed to tissue, when the lead is implanted, for providing stimulation to the tissue.
- the material of the lead body flows into the interior lumen 941 to facilitate retention of the tip electrode on the lead body of the resulting lead.
- the tip electrode 940 defines protrusions 956 on the surface that defines the interior lumen 941. These protrusions 956 facilitate retaining the tip electrode on the lead body and also resist rotation of the tip electrode around the lead body.
- the pattern of protrusions 956 form a star shape in cross-section, but it will be recognized that outer regular and irregular shapes generated by protrusions into the interior lumen can be used to resist rotation of the tip electrode around the lead body.
- the proximal end of the tip electrode 940 defines a non-circular opening 958 with protrusions 956' that form a flange with respect to an adjacent portion 960 of the interior surface of tip electrode 940 defining the interior lumen 941.
- protrusions 956', and the resulting flange-like arrangement resist rotation of the tip electrode around the lead body and also resist removal of the tip electrode from the distal end of the lead.
- a tip electrode conductor (not shown) can be attached to any portion of the tip electrode including, but not limited to, the proximal end of the tip electrode, the protrusions 956', or the surface defining the interior lumen 941.
- a pre- electrode 940' as illustrated in Figure 9B, is provided during manufacture. The lead body is formed around, and within, this pre-electrode 940'. Then the lead body and pre-electrode 940' are ground down to obtain the tip electrode 940 of Figure 9 A. This grinding process also removes excess lead body material leaving the lead body at the desired diameter. It will be understood that this embodiment can be modified to include a base with the interior lumen and a separate plug as illustrated in Figures 5-6B.
- Figure 10A illustrates an embodiment of a tip electrode 1040 with an electrode body 1042, an interior lumen 1041, and multiple arms 1060 extending from the electrode body 1042 and over the entrance 1064 to the interior lumen 1041.
- the electrode body 1042 includes at least a portion of the surface that is exposed to tissue, when the lead is implanted, for providing stimulation to the tissue.
- the material of the lead body flows into the interior lumen 941 to facilitates retention of the tip electrode within the lead body of the resulting lead.
- These arms 1060 facilitate retaining the tip electrode on the lead body and also resist rotation of the tip electrode around the lead body.
- tip electrode 1040 has three arms 1060, but it will be recognized that any number of arms can be used including, but not limited to, one, two, thee, four, six, or more arms.
- the arms 1060 can be distributed around the edge of the electrode body 1042 in any regular or irregular arrangement.
- the tip electrode conductor (not shown) can be attached to any portion of the tip electrode including, but not limited to, the proximal end of the tip electrode, the arms 1060, or the surface defining the interior lumen 1041.
- a pre- electrode 1040' as illustrated in Figure 10B, is provided during manufacture.
- the lead body is formed around, and within, this pre-electrode 1040'.
- the lead body and pre- electrode 1040' are ground down to obtain the tip electrode 1040 of Figure 10A. This grinding process also removes excess lead body material leaving the lead body at the desired diameter.
- this embodiment can be modified to include a base with the interior lumen and arms and a separate plug as illustrated in Figures 5-6B.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16165920.6A EP3111989B1 (en) | 2012-06-01 | 2013-05-31 | Leads with tip electrode for electrical stimulation systems |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261654579P | 2012-06-01 | 2012-06-01 | |
| PCT/US2013/043588 WO2013181519A2 (en) | 2012-06-01 | 2013-05-31 | Leads with tip electrode for electrical stimulation systems and methods of making and using |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP16165920.6A Division EP3111989B1 (en) | 2012-06-01 | 2013-05-31 | Leads with tip electrode for electrical stimulation systems |
| EP16165920.6A Division-Into EP3111989B1 (en) | 2012-06-01 | 2013-05-31 | Leads with tip electrode for electrical stimulation systems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2854936A2 true EP2854936A2 (en) | 2015-04-08 |
| EP2854936B1 EP2854936B1 (en) | 2016-05-25 |
Family
ID=48628939
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP16165920.6A Active EP3111989B1 (en) | 2012-06-01 | 2013-05-31 | Leads with tip electrode for electrical stimulation systems |
| EP13729559.8A Active EP2854936B1 (en) | 2012-06-01 | 2013-05-31 | Leads with tip electrode for electrical stimulation systems and methods of making and using |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP16165920.6A Active EP3111989B1 (en) | 2012-06-01 | 2013-05-31 | Leads with tip electrode for electrical stimulation systems |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8792993B2 (en) |
| EP (2) | EP3111989B1 (en) |
| JP (2) | JP5926453B2 (en) |
| CN (1) | CN104519946B (en) |
| AU (1) | AU2013267240B2 (en) |
| ES (1) | ES2585260T3 (en) |
| WO (1) | WO2013181519A2 (en) |
Families Citing this family (151)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7860570B2 (en) | 2002-06-20 | 2010-12-28 | Boston Scientific Neuromodulation Corporation | Implantable microstimulators and methods for unidirectional propagation of action potentials |
| US8321025B2 (en) | 2006-07-31 | 2012-11-27 | Cranial Medical Systems, Inc. | Lead and methods for brain monitoring and modulation |
| EP3173125B1 (en) | 2008-07-30 | 2019-03-27 | Ecole Polytechnique Fédérale de Lausanne | Apparatus for optimized stimulation of a neurological target |
| US8359107B2 (en) | 2008-10-09 | 2013-01-22 | Boston Scientific Neuromodulation Corporation | Electrode design for leads of implantable electric stimulation systems and methods of making and using |
| EP3231476B1 (en) | 2008-11-12 | 2019-06-19 | Ecole Polytechnique Fédérale de Lausanne | Microfabricated neurostimulation device |
| US8473061B2 (en) | 2009-04-16 | 2013-06-25 | Boston Scientific Neuromodulation Corporation | Deep brain stimulation current steering with split electrodes |
| US8875391B2 (en) | 2009-07-07 | 2014-11-04 | Boston Scientific Neuromodulation Corporation | Methods for making leads with radially-aligned segmented electrodes for electrical stimulation systems |
| US8887387B2 (en) | 2009-07-07 | 2014-11-18 | Boston Scientific Neuromodulation Corporation | Methods of manufacture of leads with a radially segmented electrode array |
| US8788063B2 (en) * | 2009-11-30 | 2014-07-22 | Boston Scientific Neuromodulation Corporation | Electrode array having a rail system and methods of manufacturing the same |
| US8874232B2 (en) | 2009-11-30 | 2014-10-28 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric split ring electrodes and methods of making the same |
| JP5927176B2 (en) | 2010-04-01 | 2016-06-01 | エコーレ ポリテクニーク フェデラーレ デ ローザンヌ (イーピーエフエル) | Device for interacting with neural tissue and methods of making and using it |
| US8868206B2 (en) | 2010-06-18 | 2014-10-21 | Boston Scientific Neuromodulation Corporation | Electrode array having embedded electrodes and methods of making the same |
| US8583237B2 (en) | 2010-09-13 | 2013-11-12 | Cranial Medical Systems, Inc. | Devices and methods for tissue modulation and monitoring |
| AU2011305914B2 (en) | 2010-09-21 | 2016-05-12 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using radially-aligned segmented electrodes for leads of electrical stimulation systems |
| EP2654876B1 (en) | 2010-12-23 | 2014-12-10 | Boston Scientific Neuromodulation Corporation | Method and assembly for making a medical lead including removing raised connectors by grinding |
| US8700179B2 (en) | 2011-02-02 | 2014-04-15 | Boston Scientific Neuromodulation Corporation | Leads with spiral of helical segmented electrode arrays and methods of making and using the leads |
| US20120203316A1 (en) | 2011-02-08 | 2012-08-09 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
| WO2012109331A1 (en) | 2011-02-08 | 2012-08-16 | Boston Scientific Neuromodulation Corporation | Leads with spirally arranged segmented electrodes and methods of making and using the leads |
| JP5908611B2 (en) | 2012-01-26 | 2016-04-26 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | System and method for identifying circumferential positioning of lead electrodes for electrical stimulation systems |
| WO2013148092A1 (en) | 2012-03-30 | 2013-10-03 | Boston Scientific Neuromodulation Corporation | Leads with x-ray fluorescent capsules for electrode identification and methods of manufacture and use |
| US9919148B2 (en) | 2012-05-25 | 2018-03-20 | Boston Scientific Neuromodulation Corporation | Distally curved electrical stimulation lead and methods of making and using |
| AU2013267240B2 (en) | 2012-06-01 | 2016-04-28 | Boston Scientific Neuromodulation Corporation | Leads with tip electrode for electrical stimulation systems and methods of making and using |
| US8897891B2 (en) | 2012-08-03 | 2014-11-25 | Boston Scientific Neuromodulation Corporation | Leads with electrode carrier for segmented electrodes and methods of making and using |
| EP2968933B1 (en) | 2013-03-15 | 2019-06-12 | Boston Scientific Neuromodulation Corporation | Systems for delivering sub-threshold therapy to a patient |
| EP2996765B1 (en) | 2013-05-15 | 2019-06-26 | Boston Scientific Neuromodulation Corporation | Tip electrodes for leads of electrical stimulation systems |
| AU2014274414A1 (en) | 2013-05-31 | 2015-11-19 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes and methods of making the leads |
| US9498620B2 (en) | 2013-05-31 | 2016-11-22 | Boston Scientific Neuromodulation Corporation | Leads containing segmented electrodes with non-perpendicular legs and methods of making and using |
| EP3003465A1 (en) | 2013-05-31 | 2016-04-13 | Boston Scientific Neuromodulation Corporation | Segmented electrode leads formed from pre-electrodes with depressions or apertures and methods of making |
| JP2016519985A (en) | 2013-05-31 | 2016-07-11 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Segment electrode leads formed from pre-electrodes having alignment features and methods for making and using the leads |
| JP6072986B2 (en) | 2013-07-12 | 2017-02-01 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Lead having segment electrode and method of manufacturing and using lead |
| WO2015013071A1 (en) | 2013-07-22 | 2015-01-29 | Boston Scientific Neuromodulation Corporation | Methods of manufacturing molded segmented electrode leads |
| US9089689B2 (en) | 2013-08-30 | 2015-07-28 | Boston Scientific Neuromodulation Corporation | Methods of making segmented electrode leads using flanged carrier |
| EP3077039B1 (en) | 2013-12-02 | 2021-10-13 | Boston Scientific Neuromodulation Corporation | Methods for manufacture of electrical stimulation leads with helically arranged electrodes |
| EP3142745B1 (en) | 2014-05-16 | 2018-12-26 | Aleva Neurotherapeutics SA | Device for interacting with neurological tissue |
| US11311718B2 (en) | 2014-05-16 | 2022-04-26 | Aleva Neurotherapeutics Sa | Device for interacting with neurological tissue and methods of making and using the same |
| WO2015192058A1 (en) | 2014-06-13 | 2015-12-17 | Boston Scientific Neuromodulation Corporation | Leads with electrode carriers for segmented electrodes and methods of making and using |
| US9474894B2 (en) | 2014-08-27 | 2016-10-25 | Aleva Neurotherapeutics | Deep brain stimulation lead |
| US9770598B2 (en) | 2014-08-29 | 2017-09-26 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved connector contacts for electrical stimulation systems |
| EP3204112A1 (en) | 2014-10-07 | 2017-08-16 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters |
| US9604068B2 (en) | 2014-11-10 | 2017-03-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved connector contacts for electrical stimulation systems |
| US9561362B2 (en) | 2014-11-10 | 2017-02-07 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved contact arrays for electrical stimulation systems |
| US10286205B2 (en) | 2015-02-06 | 2019-05-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved contact arrays for electrical stimulation systems |
| WO2016164361A1 (en) | 2015-04-10 | 2016-10-13 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved contact arrays for electrical stimulation systems |
| US9364659B1 (en) | 2015-04-27 | 2016-06-14 | Dantam K. Rao | Smart lead for deep brain stimulation |
| US20160375248A1 (en) | 2015-06-29 | 2016-12-29 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects |
| ES2940303T3 (en) | 2015-06-29 | 2023-05-05 | Boston Scient Neuromodulation Corp | Stimulation parameter selection systems by use of targets and direction |
| US9656093B2 (en) | 2015-07-16 | 2017-05-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector contact arrays for electrical stimulation systems |
| WO2017035158A1 (en) | 2015-08-24 | 2017-03-02 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an electrical stimulation lead |
| EP3297719B1 (en) | 2015-09-01 | 2022-02-09 | Boston Scientific Neuromodulation Corporation | Detection of lead orientation |
| US9956394B2 (en) | 2015-09-10 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Connectors for electrical stimulation systems and methods of making and using |
| US10413737B2 (en) | 2015-09-25 | 2019-09-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity |
| US10071249B2 (en) | 2015-10-09 | 2018-09-11 | Boston Scientific Neuromodulation Corporation | System and methods for clinical effects mapping for directional stimulation leads |
| US10342983B2 (en) | 2016-01-14 | 2019-07-09 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector contact arrays for electrical stimulation systems |
| CN109069824B (en) | 2016-02-02 | 2022-09-16 | 阿莱瓦神经治疗股份有限公司 | Treatment of autoimmune diseases using deep brain stimulation |
| US10814127B2 (en) | 2016-02-05 | 2020-10-27 | Boston Scientific Neuromodulation Corporation | Slotted sleeve neurostimulation device |
| AU2017214317B2 (en) | 2016-02-05 | 2019-08-22 | Boston Scientfic Neuromodulation Corporation | Implantable optical stimulation lead |
| AU2017220115B2 (en) | 2016-02-19 | 2019-11-21 | Boston Scientific Neuromodulation Corporation | Electrical stimulation cuff devices and systems |
| US10716942B2 (en) | 2016-04-25 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | System and methods for directional steering of electrical stimulation |
| US10369354B2 (en) | 2016-05-17 | 2019-08-06 | Boston Scientific Neuromodulation Corporation | Systems and method for anchoring a lead for neurostimulation of a target anatomy |
| US10493269B2 (en) | 2016-06-02 | 2019-12-03 | Boston Scientific Neuromodulation Corporation | Leads for electrostimulation of peripheral nerves and other targets |
| US10201713B2 (en) | 2016-06-20 | 2019-02-12 | Boston Scientific Neuromodulation Corporation | Threaded connector assembly and methods of making and using the same |
| WO2017223505A2 (en) | 2016-06-24 | 2017-12-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for visual analytics of clinical effects |
| US10307602B2 (en) | 2016-07-08 | 2019-06-04 | Boston Scientific Neuromodulation Corporation | Threaded connector assembly and methods of making and using the same |
| US10709888B2 (en) | 2016-07-29 | 2020-07-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an electrical stimulation system for peripheral nerve stimulation |
| US10780274B2 (en) | 2016-08-22 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for delivering spinal cord stimulation therapy |
| WO2018044881A1 (en) | 2016-09-02 | 2018-03-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and directing stimulation of neural elements |
| US10780282B2 (en) | 2016-09-20 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters |
| US10543374B2 (en) | 2016-09-30 | 2020-01-28 | Boston Scientific Neuromodulation Corporation | Connector assemblies with bending limiters for electrical stimulation systems and methods of making and using same |
| WO2018071842A1 (en) | 2016-10-14 | 2018-04-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an implanted lead |
| EP3493876B1 (en) | 2016-10-14 | 2021-03-17 | Boston Scientific Neuromodulation Corporation | Systems for closed-loop determination of stimulation parameter settings for an electrical simulation system |
| US10525257B2 (en) | 2016-10-14 | 2020-01-07 | Boston Scientific Neuromodulation Corporation | Orientation marker for implantable leads and leads, systems, and methods utilizing the orientation marker |
| US10625072B2 (en) | 2016-10-21 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Electrical stimulation methods with optical observation and devices therefor |
| US10716935B2 (en) | 2016-11-04 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads, systems and methods for stimulation of dorsal root ganglia |
| US10603485B2 (en) | 2016-11-28 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | Features in increased surface area on neuromodulation leads |
| EP3548140B1 (en) | 2016-12-02 | 2022-04-20 | Boston Scientific Neuromodulation Corporation | Systems for selecting stimulation parameters for electrical stimulation devices |
| AU2017391436B2 (en) | 2017-01-03 | 2020-06-18 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting MRI-compatible stimulation parameters |
| US10576269B2 (en) | 2017-01-03 | 2020-03-03 | Boston Scientific Neuromodulation Corporation | Force-decoupled and strain relieving lead and methods of making and using |
| US10589104B2 (en) | 2017-01-10 | 2020-03-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for creating stimulation programs based on user-defined areas or volumes |
| EP3568196B1 (en) | 2017-01-10 | 2023-11-29 | Boston Scientific Neuromodulation Corporation | Patterned stimulation for deep brain stimulation |
| US10905871B2 (en) | 2017-01-27 | 2021-02-02 | Boston Scientific Neuromodulation Corporation | Lead assemblies with arrangements to confirm alignment between terminals and contacts |
| US10709886B2 (en) | 2017-02-28 | 2020-07-14 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using |
| US10814136B2 (en) | 2017-02-28 | 2020-10-27 | Boston Scientific Neuromodulation Corporation | Toolless connector for latching stimulation leads and methods of making and using |
| US10625082B2 (en) | 2017-03-15 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Visualization of deep brain stimulation efficacy |
| US10835739B2 (en) | 2017-03-24 | 2020-11-17 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using |
| US11357986B2 (en) | 2017-04-03 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
| US10603499B2 (en) | 2017-04-07 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | Tapered implantable lead and connector interface and methods of making and using |
| US10631937B2 (en) | 2017-04-14 | 2020-04-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an implanted electrical stimulation lead |
| US10814140B2 (en) | 2017-06-26 | 2020-10-27 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and controlling optogenetic stimulation using optical stimulation systems |
| WO2019014217A1 (en) | 2017-07-14 | 2019-01-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for planning and programming electrical stimulation |
| EP3651849B1 (en) | 2017-07-14 | 2023-05-31 | Boston Scientific Neuromodulation Corporation | Estimating clinical effects of electrical stimulation |
| US10918873B2 (en) | 2017-07-25 | 2021-02-16 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an enhanced connector of an electrical stimulation system |
| US10960214B2 (en) | 2017-08-15 | 2021-03-30 | Boston Scientific Neuromodulation Corporation | Systems and methods for controlling electrical stimulation using multiple stimulation fields |
| WO2019055837A1 (en) | 2017-09-15 | 2019-03-21 | Boston Scientific Neuromodulation Corporation | Actuatable lead connector for an operating room cable assembly and methods of making and using |
| CN111629778B (en) | 2017-09-15 | 2024-07-26 | 波士顿科学神经调制公司 | Offset lead connector for operating room cable assemblies and methods of making and using the same |
| US11139603B2 (en) | 2017-10-03 | 2021-10-05 | Boston Scientific Neuromodulation Corporation | Connectors with spring contacts for electrical stimulation systems and methods of making and using same |
| US11103716B2 (en) | 2017-11-13 | 2021-08-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a low-profile control module for an electrical stimulation system |
| WO2019099887A1 (en) | 2017-11-17 | 2019-05-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating intermittent stimulation using electrical stimulation systems |
| EP3737464B1 (en) | 2018-01-11 | 2026-02-25 | Boston Scientific Neuromodulation Corporation | Systems for stimulation for glial modulation |
| WO2019143574A1 (en) | 2018-01-16 | 2019-07-25 | Boston Scientific Neuromodulation Corporation | An electrical stimulation system with a case-neutral battery and a control module for such a system |
| US11103712B2 (en) | 2018-01-16 | 2021-08-31 | Boston Scientific Neuromodulation Corporation | Connector assemblies with novel spacers for electrical stimulation systems and methods of making and using same |
| US10702692B2 (en) | 2018-03-02 | 2020-07-07 | Aleva Neurotherapeutics | Neurostimulation device |
| US11058870B2 (en) | 2018-03-09 | 2021-07-13 | Boston Scientific Neuromodulation Corporation | Burr hole plugs for electrical stimulation systems and methods of making and using |
| US11013913B2 (en) | 2018-03-16 | 2021-05-25 | Boston Scientific Neuromodulation Corporation | Kits and methods for securing a burr hole plugs for stimulation systems |
| WO2019183054A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Optical stimulation systems with calibration and methods of making and using |
| WO2019183082A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Implantable prostheses for reducing visibility of bulging from implanted medical devices |
| EP3768372A1 (en) | 2018-03-23 | 2021-01-27 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making and using |
| EP3784332B1 (en) | 2018-04-27 | 2023-04-26 | Boston Scientific Neuromodulation Corporation | Systems for visualizing and programming electrical stimulation |
| JP7295141B2 (en) | 2018-04-27 | 2023-06-20 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Multimodal electrical stimulation system and methods of making and using |
| US11172959B2 (en) | 2018-05-02 | 2021-11-16 | Boston Scientific Neuromodulation Corporation | Long, flexible sheath and lead blank and systems and methods of making and using |
| EP3790623B1 (en) | 2018-05-11 | 2023-07-05 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system |
| AU2019302442B2 (en) | 2018-07-09 | 2022-06-30 | Boston Scientific Neuromodulation Corporation | Directional electrical stimulation leads and systems for spinal cord stimulation |
| US11224743B2 (en) | 2018-09-21 | 2022-01-18 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using modular leads for electrical stimulation systems |
| AU2019378702B2 (en) | 2018-11-16 | 2022-09-01 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making |
| US11167128B2 (en) | 2018-11-16 | 2021-11-09 | Boston Scientific Neuromodulation Corporation | Directional electrical stimulation leads, systems and methods for spinal cord stimulation |
| AU2020226356B2 (en) | 2019-02-19 | 2022-12-08 | Boston Scientific Neuromodulation Corporation | Lead introducers and systems and methods including the lead introducers |
| WO2020205843A1 (en) | 2019-04-01 | 2020-10-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using a low-profile control module for an electrical stimulation system |
| US11357992B2 (en) | 2019-05-03 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system and methods of making and using |
| US20220362560A1 (en) | 2019-10-28 | 2022-11-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for measuring temperature on or near an implantable medical device |
| US11806532B2 (en) * | 2019-11-26 | 2023-11-07 | Heraeus Medical Components Llc | Implantable lead with asymmetric fiducial marker |
| EP4076625A1 (en) | 2020-02-19 | 2022-10-26 | Boston Scientific Neuromodulation Corporation | Methods and systems for treatment of insomnia using deep brain stimulation |
| EP4168110B1 (en) | 2020-09-04 | 2025-09-24 | Boston Scientific Neuromodulation Corporation | Stimulation systems with a lens arrangement for light coupling |
| EP4196209A1 (en) | 2020-11-04 | 2023-06-21 | Boston Scientific Neuromodulation Corporation | Methods and systems for managing access to implantable medical devices |
| WO2022103590A1 (en) | 2020-11-11 | 2022-05-19 | Boston Scientific Neuromodulation Corporation | Voice command handler for programming stimulation systems and methods of using |
| WO2022182892A1 (en) | 2021-02-25 | 2022-09-01 | Boston Scientific Neuromodulation Corporation | Methods and systems for deep brain stimulation of the nucleus basalis of meynert |
| US12427332B2 (en) | 2021-04-08 | 2025-09-30 | Boston Scientific Neuromodulation Corporation | Photobiomodulation system and delivery device and methods of making and using |
| US12403315B2 (en) | 2021-04-27 | 2025-09-02 | Boston Scientific Neuromodulation Corporation | Systems and methods for automated programming of electrical stimulation |
| EP4313262B1 (en) | 2021-05-21 | 2025-04-02 | Boston Scientific Neuromodulation Corporation | Electrical stimulation devices |
| WO2022265977A1 (en) | 2021-06-15 | 2022-12-22 | Boston Scientific Neuromodulation Corporation | Methods and systems for estimating neural activation by stimulation using a stimulation system |
| US12343547B2 (en) | 2021-08-19 | 2025-07-01 | Boston Scientific Neuromodulation Corporation | Connectors for an electrical stimulation system and methods of making and using |
| US12589252B2 (en) | 2021-08-19 | 2026-03-31 | Boston Scientific Neuromodulation Corporation | Connector assembly with capacitive contacts for an electrical stimulation system and methods of making and using |
| US12527956B2 (en) | 2021-12-09 | 2026-01-20 | Boston Scientific Neuromodulation Corporation | Methods and systems for monitoring or assessing movement disorders or other physiological parameters using a stimulation system |
| WO2023107444A1 (en) | 2021-12-10 | 2023-06-15 | Boston Scientific Neuromodulation Corporation | Methods and systems for determining and using an intensity index for electrical stimulation |
| US12471831B2 (en) | 2021-12-10 | 2025-11-18 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating and using response maps for electrical stimulation |
| AU2023218273C1 (en) | 2022-02-10 | 2026-04-02 | Boston Scientific Neuromodulation Corporation | Automatic therapy adjustment based on sensors |
| EP4440687A1 (en) | 2022-02-24 | 2024-10-09 | Boston Scientific Neuromodulation Corporation | Systems and methods for using cost parameters for programming electrical stimulation |
| WO2023167872A1 (en) | 2022-03-02 | 2023-09-07 | Boston Scientific Neuromodulation Corporation | Systems and methods for monitoring stimulation drift in an electrical stimulation system |
| EP4368242A1 (en) | 2022-11-14 | 2024-05-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating and using stimulation programs with temporal variation |
| WO2024129609A1 (en) | 2022-12-14 | 2024-06-20 | Boston Scientific Neuromodulation Corporation | Systems and methods for monitoring and revising electrical stimulation |
| EP4398258A3 (en) | 2023-01-04 | 2024-08-28 | Boston Scientific Neuromodulation Corporation | Systems and methods incorporating a light therapy user interface for optical modulation |
| EP4646260A1 (en) | 2023-03-22 | 2025-11-12 | Boston Scientific Neuromodulation Corporation | Systems for moving stimulation using anatomical directional controls |
| US20240359015A1 (en) | 2023-04-28 | 2024-10-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for modifying stimulation in response to a change in a symptom, therapeutic effect, or side effect |
| US20250010079A1 (en) | 2023-07-06 | 2025-01-09 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting electrodes and providing stimulation |
| WO2025034507A1 (en) | 2023-08-10 | 2025-02-13 | Boston Scientific Neuromodulation Corporation | Enhancing neuromodulation for sleep |
| EP4735105A2 (en) | 2023-08-11 | 2026-05-06 | Boston Scientific Neuromodulation Corporation | Methods and systems for control and modification of stimulation |
| AU2024324981A1 (en) | 2023-08-16 | 2026-02-05 | Boston Scientific Neuromodulation Corporation | Integration of fiber tracts into deep brain stimulation targeting |
| US20250058107A1 (en) | 2023-08-16 | 2025-02-20 | Boston Scientific Neuromodulation Corporation | Integration of related probability shells into deep brain stimulation targeting |
| WO2025038718A1 (en) | 2023-08-16 | 2025-02-20 | Boston Scientific Neuromodulation Corporation | Photobiomodulation of basal forebrain to improve cognition |
| WO2025054405A1 (en) | 2023-09-07 | 2025-03-13 | Boston Scientific Neuromodulation Corporation | System and method for modulating neural synchrony |
| WO2025075826A1 (en) | 2023-10-02 | 2025-04-10 | Boston Scientific Neuromodulation Corporation | Lead introducers and systems including the lead introducers |
| WO2025096870A1 (en) | 2023-11-02 | 2025-05-08 | Boston Scientific Neuromodulation Corporation | Optimization of dbs program using a prespecified selection of contacts |
| US20250242159A1 (en) | 2024-01-30 | 2025-07-31 | Boston Scientific Neuromodulation Corporation | System and method for combined photobiomodulation and electrical stimulation for epilepsy |
Family Cites Families (130)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2295308A (en) | 1938-02-26 | 1942-09-08 | Gen Electric | High speed reclosing mechanism |
| US3942536A (en) * | 1971-03-15 | 1976-03-09 | Mieczyslaw Mirowski | Cardioverting device having single intravascular catheter electrode system and method for its use |
| US4413636A (en) * | 1979-11-19 | 1983-11-08 | Phillip R. Beutel | Catheter |
| US4630611A (en) | 1981-02-02 | 1986-12-23 | Medtronic, Inc. | Orthogonally-sensing lead |
| US4602624A (en) | 1984-10-11 | 1986-07-29 | Case Western Reserve University | Implantable cuff, method of manufacture, and method of installation |
| US4844099A (en) * | 1986-11-24 | 1989-07-04 | Telectronics, N.V. | Porous pacemaker electrode tip using a porous substrate |
| US4744370A (en) | 1987-04-27 | 1988-05-17 | Cordis Leads, Inc. | Lead assembly with selectable electrode connection |
| US5000194A (en) | 1988-08-25 | 1991-03-19 | Cochlear Corporation | Array of bipolar electrodes |
| US5230349A (en) * | 1988-11-25 | 1993-07-27 | Sensor Electronics, Inc. | Electrical heating catheter |
| US5097843A (en) | 1990-04-10 | 1992-03-24 | Siemens-Pacesetter, Inc. | Porous electrode for a pacemaker |
| US5135001A (en) | 1990-12-05 | 1992-08-04 | C. R. Bard, Inc. | Ultrasound sheath for medical diagnostic instruments |
| AU1899292A (en) * | 1991-05-24 | 1993-01-08 | Ep Technologies Inc | Combination monophasic action potential/ablation catheter and high-performance filter system |
| EP0580928A1 (en) | 1992-07-31 | 1994-02-02 | ARIES S.r.l. | A spinal electrode catheter |
| ZA948393B (en) | 1993-11-01 | 1995-06-26 | Polartechnics Ltd | Method and apparatus for tissue type recognition |
| US5458629A (en) | 1994-02-18 | 1995-10-17 | Medtronic, Inc. | Implantable lead ring electrode and method of making |
| US5458596A (en) * | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
| US5522874A (en) | 1994-07-28 | 1996-06-04 | Gates; James T. | Medical lead having segmented electrode |
| DE69734065D1 (en) | 1996-03-07 | 2005-09-29 | Axon Engineering Inc | POLYMER METAL FILM STRUCTURE FOR NEURONAL STIMULATING ELECTRODES |
| US5713922A (en) | 1996-04-25 | 1998-02-03 | Medtronic, Inc. | Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain |
| US5711316A (en) | 1996-04-30 | 1998-01-27 | Medtronic, Inc. | Method of treating movement disorders by brain infusion |
| US5843148A (en) | 1996-09-27 | 1998-12-01 | Medtronic, Inc. | High resolution brain stimulation lead and method of use |
| US5938688A (en) | 1997-10-22 | 1999-08-17 | Cornell Research Foundation, Inc. | Deep brain stimulation method |
| US6161047A (en) | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
| US6134478A (en) | 1998-06-05 | 2000-10-17 | Intermedics Inc. | Method for making cardiac leads with zone insulated electrodes |
| US6064905A (en) | 1998-06-18 | 2000-05-16 | Cordis Webster, Inc. | Multi-element tip electrode mapping catheter |
| AU4959799A (en) | 1998-06-26 | 2000-01-17 | Advanced Bionics Corporation | Programmable current output stimulus stage for implantable device |
| US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
| US6018684A (en) | 1998-07-30 | 2000-01-25 | Cardiac Pacemakers, Inc. | Slotted pacing/shocking electrode |
| US6564078B1 (en) | 1998-12-23 | 2003-05-13 | Nuvasive, Inc. | Nerve surveillance cannula systems |
| EP1146816B1 (en) | 1998-12-23 | 2005-10-12 | Nuvasive Inc. | Nerve surveillance cannulae systems |
| US6393325B1 (en) | 1999-01-07 | 2002-05-21 | Advanced Bionics Corporation | Directional programming for implantable electrode arrays |
| US6167311A (en) | 1999-06-14 | 2000-12-26 | Electro Core Techniques, Llc | Method of treating psychological disorders by brain stimulation within the thalamus |
| US6516227B1 (en) | 1999-07-27 | 2003-02-04 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
| US7949395B2 (en) | 1999-10-01 | 2011-05-24 | Boston Scientific Neuromodulation Corporation | Implantable microdevice with extended lead and remote electrode |
| US6556873B1 (en) | 1999-11-29 | 2003-04-29 | Medtronic, Inc. | Medical electrical lead having variable bending stiffness |
| US6609029B1 (en) | 2000-02-04 | 2003-08-19 | Advanced Bionics Corporation | Clip lock mechanism for retaining lead |
| DE60131952T2 (en) | 2000-02-09 | 2008-12-18 | Medtronic Transneuronix, Inc. | MEDICAL IMPLANTABLE DEVICE FOR ELECTROSTIMULATION WITH DISCRETE MICRO-ELECTRODES |
| US6741892B1 (en) | 2000-03-10 | 2004-05-25 | Advanced Bionics Corporation | Movable contact locking mechanism for spinal cord stimulator lead connector |
| US6510347B2 (en) | 2000-08-17 | 2003-01-21 | William N. Borkan | Spinal cord stimulation leads |
| US6757970B1 (en) | 2000-11-07 | 2004-07-06 | Advanced Bionics Corporation | Method of making multi-contact electrode array |
| WO2002045795A2 (en) | 2000-12-07 | 2002-06-13 | Medtronic, Inc. | Directional brain stimulation and recording leads |
| GB0104982D0 (en) | 2001-02-28 | 2001-04-18 | Gill Steven | Electrode |
| US6766203B2 (en) | 2001-04-05 | 2004-07-20 | Pacesetter, Inc. | Body implantable lead with improved tip electrode assembly |
| US6678564B2 (en) | 2001-12-06 | 2004-01-13 | Advanced Cochlear Systems, Inc. | Bio-implant and method of making the same |
| US8364278B2 (en) | 2002-01-29 | 2013-01-29 | Boston Scientific Neuromodulation Corporation | Lead assembly for implantable microstimulator |
| US8000802B2 (en) | 2002-04-22 | 2011-08-16 | Medtronic, Inc. | Implantable lead with coplanar contact coupling |
| US7027852B2 (en) | 2002-05-21 | 2006-04-11 | Pacesetter, Inc. | Lead with distal tip surface electrodes connected in parallel |
| US7860570B2 (en) | 2002-06-20 | 2010-12-28 | Boston Scientific Neuromodulation Corporation | Implantable microstimulators and methods for unidirectional propagation of action potentials |
| US7292890B2 (en) | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
| US7437193B2 (en) | 2002-06-28 | 2008-10-14 | Boston Scientific Neuromodulation Corporation | Microstimulator employing improved recharging reporting and telemetry techniques |
| US7047084B2 (en) | 2002-11-20 | 2006-05-16 | Advanced Neuromodulation Systems, Inc. | Apparatus for directionally stimulating nerve tissue |
| US20050038489A1 (en) | 2003-08-14 | 2005-02-17 | Grill Warren M. | Electrode array for use in medical stimulation and methods thereof |
| WO2005053789A2 (en) | 2003-11-25 | 2005-06-16 | Advanced Neuromodulation Systems, Inc. | Directional stimulation lead and orientation system, and improved percutaneous-insertion needle and method of implanting a lead |
| US20050246007A1 (en) * | 2004-04-28 | 2005-11-03 | Medtronic, Inc. | Novel lead body assemblies |
| US7489971B1 (en) | 2004-06-05 | 2009-02-10 | Advanced Neuromodulation Systems, Inc. | Notched electrode for electrostimulation lead |
| EP1786509A4 (en) | 2004-07-27 | 2010-01-13 | Cleveland Clinic Foundation | Thalamic stimulation device |
| US20060041297A1 (en) * | 2004-08-23 | 2006-02-23 | Medtronic, Inc. | Novel electrode assembly for medical electrical leads |
| US7809446B2 (en) | 2005-01-05 | 2010-10-05 | Boston Scientific Neuromodulation Corporation | Devices and methods for brain stimulation |
| US8066702B2 (en) | 2005-01-11 | 2011-11-29 | Rittman Iii William J | Combination electrical stimulating and infusion medical device and method |
| DE602006010515D1 (en) | 2005-01-31 | 2009-12-31 | Medtronic Inc | METHOD FOR PRODUCING A MEDICAL LINE |
| US8565898B2 (en) | 2005-04-28 | 2013-10-22 | Medtronic, Inc. | Rate control during AF using cellular intervention to modulate AV node |
| US7761165B1 (en) | 2005-09-29 | 2010-07-20 | Boston Scientific Neuromodulation Corporation | Implantable stimulator with integrated plastic housing/metal contacts and manufacture and use |
| US8700178B2 (en) | 2005-12-27 | 2014-04-15 | Boston Scientific Neuromodulation Corporation | Stimulator leads and methods for lead fabrication |
| US7672734B2 (en) | 2005-12-27 | 2010-03-02 | Boston Scientific Neuromodulation Corporation | Non-linear electrode array |
| US7244150B1 (en) | 2006-01-09 | 2007-07-17 | Advanced Bionics Corporation | Connector and methods of fabrication |
| US7822483B2 (en) | 2006-02-24 | 2010-10-26 | Medtronic, Inc. | Electrical and activation field models for configuring stimulation therapy |
| US7848802B2 (en) | 2006-02-24 | 2010-12-07 | Medtronic, Inc. | Programming interface with a concentric axial view of a stimulation lead with complex electrode array geometry |
| DE602006009712D1 (en) | 2006-03-02 | 2009-11-19 | St Jude Medical | MEDICAL IMPLANTABLE LINE AND METHOD FOR THE PRODUCTION THEREOF |
| US8175710B2 (en) | 2006-03-14 | 2012-05-08 | Boston Scientific Neuromodulation Corporation | Stimulator system with electrode array and the method of making the same |
| US7974706B2 (en) | 2006-03-30 | 2011-07-05 | Boston Scientific Neuromodulation Corporation | Electrode contact configurations for cuff leads |
| US7702387B2 (en) * | 2006-06-08 | 2010-04-20 | Greatbatch Ltd. | Tank filters adaptable for placement with a guide wire, in series with the lead wires or circuits of active medical devices to enhance MRI compatibility |
| US8321025B2 (en) | 2006-07-31 | 2012-11-27 | Cranial Medical Systems, Inc. | Lead and methods for brain monitoring and modulation |
| EP2059294B1 (en) | 2006-08-07 | 2018-10-10 | Alpha Omega Neuro Technologies Ltd. | Cerebral electrodes |
| US8224450B2 (en) | 2006-09-18 | 2012-07-17 | Boston Scientific Neuromodulation Corporation | Feed through interconnect assembly for an implantable stimulation system and methods of making and using |
| EP2069003B1 (en) | 2006-09-26 | 2014-11-12 | Sapiens Steering Brain Stimulation B.V. | Tissue stimulation apparatus |
| US20080103580A1 (en) | 2006-10-31 | 2008-05-01 | Medtronic, Inc. | Implantable medical elongated member with dual purpose conduit |
| EP2078263B1 (en) | 2006-10-31 | 2019-06-12 | Semiconductor Energy Laboratory Co, Ltd. | Semiconductor device |
| US20080114230A1 (en) | 2006-11-14 | 2008-05-15 | Bruce Addis | Electrode support |
| US7979140B2 (en) | 2006-12-12 | 2011-07-12 | Alfred E. Mann Foundation For Scientific Research | Segmented electrode |
| WO2008072125A1 (en) | 2006-12-13 | 2008-06-19 | Koninklijke Philips Electronics, N.V. | First time right placement of a dbs lead |
| US7668601B2 (en) | 2007-04-26 | 2010-02-23 | Medtronic, Inc. | Implantable medical lead with multiple electrode configurations |
| US20090054947A1 (en) | 2007-08-20 | 2009-02-26 | Medtronic, Inc. | Electrode configurations for directional leads |
| US9192409B2 (en) | 2008-01-23 | 2015-11-24 | Boston Scientific Neuromodulation Corporation | Steerable stylet handle assembly |
| US9220889B2 (en) | 2008-02-11 | 2015-12-29 | Intelect Medical, Inc. | Directional electrode devices with locating features |
| US8019440B2 (en) | 2008-02-12 | 2011-09-13 | Intelect Medical, Inc. | Directional lead assembly |
| US8600518B2 (en) | 2008-04-30 | 2013-12-03 | Boston Scientific Neuromodulation Corporation | Electrodes for stimulation leads and methods of manufacture and use |
| WO2009137088A2 (en) | 2008-05-07 | 2009-11-12 | Cardiac Pacemakers, Inc. | Lead assembly and related methods |
| US8688235B1 (en) | 2008-07-22 | 2014-04-01 | Boston Scientific Neuromodulation Corporation | Lead with transition and methods of manufacture and use |
| US20100076535A1 (en) * | 2008-09-25 | 2010-03-25 | Boston Scientific Neuromodulation Corporation | Leads with non-circular-shaped distal ends for brain stimulation systems and methods of making and using |
| US8335551B2 (en) | 2008-09-29 | 2012-12-18 | Chong Il Lee | Method and means for connecting a large number of electrodes to a measuring device |
| US8359107B2 (en) | 2008-10-09 | 2013-01-22 | Boston Scientific Neuromodulation Corporation | Electrode design for leads of implantable electric stimulation systems and methods of making and using |
| EP3231476B1 (en) | 2008-11-12 | 2019-06-19 | Ecole Polytechnique Fédérale de Lausanne | Microfabricated neurostimulation device |
| JP2012508624A (en) | 2008-11-13 | 2012-04-12 | プロテウス バイオメディカル インコーポレイテッド | Multiplexed multiple electrode nerve stimulator |
| US9833616B2 (en) * | 2009-01-02 | 2017-12-05 | Medtronic, Inc. | System and method for cardiac lead |
| US8126557B2 (en) | 2009-02-13 | 2012-02-28 | Pacesetter, Inc. | Lead connector pin and body assembly and method of manufacture |
| US20100222860A1 (en) * | 2009-03-02 | 2010-09-02 | Pacesetter, Inc. | Implantable Leads Having Mechanisms to Impede Over-Rotation of Fixation Mechanisms |
| US8473061B2 (en) * | 2009-04-16 | 2013-06-25 | Boston Scientific Neuromodulation Corporation | Deep brain stimulation current steering with split electrodes |
| US8225504B2 (en) | 2009-04-24 | 2012-07-24 | Advanced Neuromodulation Systems, Inc. | Medical leads with segmented electrodes and methods of fabrication thereof |
| US8046909B2 (en) | 2009-04-24 | 2011-11-01 | Advanced Neuromodulation Systems, Inc. | Method of fabricating stimulation lead |
| US8250755B2 (en) | 2009-04-24 | 2012-08-28 | Advanced Neuromodulation Systems, Inc. | Process for fabricating a medical lead |
| US20100287770A1 (en) | 2009-05-14 | 2010-11-18 | Cochlear Limited | Manufacturing an electrode carrier for an implantable medical device |
| US8887387B2 (en) | 2009-07-07 | 2014-11-18 | Boston Scientific Neuromodulation Corporation | Methods of manufacture of leads with a radially segmented electrode array |
| US8875391B2 (en) | 2009-07-07 | 2014-11-04 | Boston Scientific Neuromodulation Corporation | Methods for making leads with radially-aligned segmented electrodes for electrical stimulation systems |
| US20110047795A1 (en) | 2009-09-01 | 2011-03-03 | Kevin Turner | Medical leads with segmented electrodes and methods of fabrication thereof |
| US20110077699A1 (en) | 2009-09-30 | 2011-03-31 | John Swanson | Medical leads with segmented electrodes and methods of fabrication thereof |
| US8874232B2 (en) | 2009-11-30 | 2014-10-28 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric split ring electrodes and methods of making the same |
| US8295944B2 (en) | 2009-11-30 | 2012-10-23 | Boston Scientific Neuromodulation Corporation | Electrode array with electrodes having cutout portions and methods of making the same |
| US8788063B2 (en) | 2009-11-30 | 2014-07-22 | Boston Scientific Neuromodulation Corporation | Electrode array having a rail system and methods of manufacturing the same |
| US8391985B2 (en) | 2009-11-30 | 2013-03-05 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric windowed cylinder electrodes and methods of making the same |
| US8571665B2 (en) | 2010-03-23 | 2013-10-29 | Boston Scientific Neuromodulation Corporation | Helical radial spacing of contacts on a cylindrical lead |
| US9162053B2 (en) | 2010-04-02 | 2015-10-20 | Boston Scientific Neuromodulation Corporation | Directional lead assembly |
| US8868206B2 (en) | 2010-06-18 | 2014-10-21 | Boston Scientific Neuromodulation Corporation | Electrode array having embedded electrodes and methods of making the same |
| WO2012009181A2 (en) | 2010-07-16 | 2012-01-19 | Boston Scientific Neuromodulation Corporation | Systems and methods for radial steering of electrode arrays |
| US20120046710A1 (en) | 2010-08-18 | 2012-02-23 | Boston Scientific Neuromodulation Corporation | Methods, systems, and devices for deep brain stimulation using helical movement of the centroid of stimulation |
| US8583237B2 (en) | 2010-09-13 | 2013-11-12 | Cranial Medical Systems, Inc. | Devices and methods for tissue modulation and monitoring |
| AU2011305914B2 (en) | 2010-09-21 | 2016-05-12 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using radially-aligned segmented electrodes for leads of electrical stimulation systems |
| EP2654876B1 (en) | 2010-12-23 | 2014-12-10 | Boston Scientific Neuromodulation Corporation | Method and assembly for making a medical lead including removing raised connectors by grinding |
| US8700179B2 (en) | 2011-02-02 | 2014-04-15 | Boston Scientific Neuromodulation Corporation | Leads with spiral of helical segmented electrode arrays and methods of making and using the leads |
| JP2014511227A (en) | 2011-02-08 | 2014-05-15 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Method of manufacturing a lead having segmented electrodes for an electrical stimulation system |
| US20120203316A1 (en) | 2011-02-08 | 2012-08-09 | Boston Scientific Neuromodulation Corporation | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using |
| WO2012109331A1 (en) | 2011-02-08 | 2012-08-16 | Boston Scientific Neuromodulation Corporation | Leads with spirally arranged segmented electrodes and methods of making and using the leads |
| US9138576B2 (en) | 2011-10-28 | 2015-09-22 | Medtronic, Inc. | Lead end having inner support |
| JP5908611B2 (en) | 2012-01-26 | 2016-04-26 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | System and method for identifying circumferential positioning of lead electrodes for electrical stimulation systems |
| WO2013148092A1 (en) | 2012-03-30 | 2013-10-03 | Boston Scientific Neuromodulation Corporation | Leads with x-ray fluorescent capsules for electrode identification and methods of manufacture and use |
| WO2013162775A2 (en) | 2012-04-27 | 2013-10-31 | Medtronic, Inc. | Structures and techniques for medical lead fabrication |
| US20130317587A1 (en) | 2012-05-25 | 2013-11-28 | Boston Scientific Neuromodulation Corporation | Methods for stimulating the dorsal root ganglion with a lead having segmented electrodes |
| AU2013267240B2 (en) | 2012-06-01 | 2016-04-28 | Boston Scientific Neuromodulation Corporation | Leads with tip electrode for electrical stimulation systems and methods of making and using |
| US9555234B2 (en) | 2012-07-26 | 2017-01-31 | Medtronic, Inc. | Implantable medical leads |
| US8897891B2 (en) | 2012-08-03 | 2014-11-25 | Boston Scientific Neuromodulation Corporation | Leads with electrode carrier for segmented electrodes and methods of making and using |
| EP2996765B1 (en) * | 2013-05-15 | 2019-06-26 | Boston Scientific Neuromodulation Corporation | Tip electrodes for leads of electrical stimulation systems |
-
2013
- 2013-05-31 AU AU2013267240A patent/AU2013267240B2/en active Active
- 2013-05-31 EP EP16165920.6A patent/EP3111989B1/en active Active
- 2013-05-31 CN CN201380029009.9A patent/CN104519946B/en not_active Expired - Fee Related
- 2013-05-31 EP EP13729559.8A patent/EP2854936B1/en active Active
- 2013-05-31 US US13/906,776 patent/US8792993B2/en active Active
- 2013-05-31 WO PCT/US2013/043588 patent/WO2013181519A2/en not_active Ceased
- 2013-05-31 JP JP2015515232A patent/JP5926453B2/en not_active Expired - Fee Related
- 2013-05-31 ES ES13729559.8T patent/ES2585260T3/en active Active
-
2014
- 2014-06-13 US US14/304,688 patent/US8996132B2/en active Active
-
2016
- 2016-04-21 JP JP2016085376A patent/JP6189472B2/en active Active
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2013181519A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013267240A1 (en) | 2014-11-27 |
| AU2013267240B2 (en) | 2016-04-28 |
| US20130325091A1 (en) | 2013-12-05 |
| JP2016129797A (en) | 2016-07-21 |
| US20140296953A1 (en) | 2014-10-02 |
| US8996132B2 (en) | 2015-03-31 |
| ES2585260T3 (en) | 2016-10-04 |
| EP3111989B1 (en) | 2021-09-01 |
| CN104519946B (en) | 2016-10-19 |
| JP5926453B2 (en) | 2016-05-25 |
| EP2854936B1 (en) | 2016-05-25 |
| EP3111989A1 (en) | 2017-01-04 |
| JP6189472B2 (en) | 2017-08-30 |
| WO2013181519A3 (en) | 2014-03-27 |
| US8792993B2 (en) | 2014-07-29 |
| JP2015517883A (en) | 2015-06-25 |
| CN104519946A (en) | 2015-04-15 |
| WO2013181519A2 (en) | 2013-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8792993B2 (en) | Leads with tip electrode for electrical stimulation systems and methods of making and using | |
| US9775988B2 (en) | Electrical stimulation leads with helically arranged electrodes and methods of making and using | |
| US8649879B2 (en) | Leads with retention features for segmented electrodes and methods of making and using the leads | |
| US9248272B2 (en) | Segmented electrode leads formed from pre-electrodes with depressions or apertures and methods of making and using | |
| EP3030309B1 (en) | Systems using segmented tip electrodes for leads of electrical simulation systems | |
| US9566747B2 (en) | Method of making an electrical stimulation lead | |
| US9498620B2 (en) | Leads containing segmented electrodes with non-perpendicular legs and methods of making and using | |
| US9283375B2 (en) | Leads with segmented electrodes for electrical stimulation of planar regions and methods of making and using | |
| US20140358210A1 (en) | Methods for manufacturing segmented electrode leads using a removable ring and the leads formed thereby |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20141224 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20151207 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Ref country code: AT Ref legal event code: REF Ref document number: 801746 Country of ref document: AT Kind code of ref document: T Effective date: 20160615 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013008003 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2585260 Country of ref document: ES Kind code of ref document: T3 Effective date: 20161004 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160825 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 801746 Country of ref document: AT Kind code of ref document: T Effective date: 20160525 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160926 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160826 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160531 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160531 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160531 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013008003 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20170228 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20170331 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160531 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160725 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20170531 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170531 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20130531 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160531 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160531 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240603 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20250423 Year of fee payment: 13 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20250423 Year of fee payment: 13 |